BridgeMD
New treatment option for Post-Stroke Cognitive Impairment (PSCI)
Official title Electroacupuncture Treatment for Post-stroke Cognitive Impairment
ClinicalTrials.gov ID: NCT07208019
What this study is testing
- What it's testing
- Stroke is a global public health issue, and it has become a leading cause of death and disability in China. With the rapid aging of the Chinese population, its incidence rate is continuously rising.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 80
You may be able to join if
- According to the Western diagnostic criteria for vascular cognitive impairment outlined in the "Chinese Guidelines for the Diagnosis and Treatment of...
- Meets the traditional Chinese medicine diagnostic criteria for vascular cognitive impairment in the "Guidelines for Traditional Chinese Medicine...
- The Mini Mental State Examination (MMSE) score ranges from 12-24, while the Montreal Cognitive Assessment (MoCA) score is below 24; Having cognitive...
- Age between 35-80 years old;
- Have basic communication skills, with Mandarin as the main language (communication language is sufficient), and have at least one stable caregiver;
You likely can't join if
- Merge serious primary chronic diseases such as heart, liver, kidney, endocrine system, and hematopoietic system, as well as severe cardiovascular and...
- Skin diseases or scar constitution such as herpes and ulceration are easy to appear on the body surface, which is not suitable for acupuncture and...
- Not suitable for repetitive MRI examinations, such as claustrophobia, arterial aneurysm embolization, etc;
- Patients with cognitive impairment or other severe neurological or mental disorders prior to the onset of this illness, and unstable control;
- Patients identified by other clinical trial personnel as unsuitable for this study;
- Participated in clinical research on related diseases in the past 3 months;
See the full eligibility criteria
- According to the Western diagnostic criteria for vascular cognitive impairment outlined in the "Chinese Guidelines for the Diagnosis and Treatment of Vascular Cognitive Impairment (2024 Edition)" developed by the...
- Meets the traditional Chinese medicine diagnostic criteria for vascular cognitive impairment in the "Guidelines for Traditional Chinese Medicine Diagnosis and Treatment of Vascular Mild Cognitive Impairment (2024)";
- The Mini Mental State Examination (MMSE) score ranges from 12-24, while the Montreal Cognitive Assessment (MoCA) score is below 24; Having cognitive impairment but not reaching the level of severe dementia; The National...
- Age between 35-80 years old;
- Have basic communication skills, with Mandarin as the main language (communication language is sufficient), and have at least one stable caregiver;
- Sign the informed consent form.
- Merge serious primary chronic diseases such as heart, liver, kidney, endocrine system, and hematopoietic system, as well as severe cardiovascular and cerebrovascular diseases;
- Skin diseases or scar constitution such as herpes and ulceration are easy to appear on the body surface, which is not suitable for acupuncture and moxibustion treatment;
- Not suitable for repetitive MRI examinations, such as claustrophobia, arterial aneurysm embolization, etc;
- Patients with cognitive impairment or other severe neurological or mental disorders prior to the onset of this illness, and unstable control;
- Patients identified by other clinical trial personnel as unsuitable for this study;
- Participated in clinical research on related diseases in the past 3 months;
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.